Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug

DRUG2 trials

Sponsors

Laboratorios Andromaco S.A.

Conditions

BioequivalenceTherapeutic Equivalency

Phase 1

Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

CompletedNCT04230070

Laboratorios Andromaco S.A.Bioequivalence

Start: 2020-10-24End: 2020-11-17Updated: 2021-02-10

Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

CompletedNCT05282940

Laboratorios Andromaco S.A.Therapeutic Equivalency

Start: 2022-02-26End: 2022-04-08Updated: 2022-06-02